• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[科林法尔抗心绞痛作用的机制]

[Mechanism of the anti-anginal action of korinfar].

作者信息

Sadkovaia R M, Zin'kovskaia T M, Golubev A D

出版信息

Farmakol Toksikol. 1986 Sep-Oct;49(5):90-2.

PMID:3770183
Abstract

The effect of corinfar on the blood plasma Ca2+ content and oxyhemoglobin dissociation curve was studied in 52 patients with ischemic heart disease. The drug was administered in a dose of 60 mg/day and to 5 patients in a dose of 90 mg/day for 2 weeks. A complete disappearance of angina attacks and ECG normalization were observed in 37 patients, a good effect was noted in 30 patients and no effect was seen in 13 patients. A significant decrease of Ca2+ content during treatment was noted in patients with effort angina of mild and moderate degrees. Parallelism between Ca2+ content decrease and the drug efficacy was revealed.

摘要

在52例缺血性心脏病患者中研究了科里法(corinfar)对血浆Ca2+含量和氧合血红蛋白解离曲线的影响。药物剂量为60毫克/天,给5例患者的剂量为90毫克/天,持续2周。观察到37例患者心绞痛发作完全消失且心电图恢复正常,30例患者效果良好,13例患者无效果。轻度和中度劳力性心绞痛患者在治疗期间Ca2+含量显著降低。发现Ca2+含量降低与药物疗效之间存在平行关系。

相似文献

1
[Mechanism of the anti-anginal action of korinfar].[科林法尔抗心绞痛作用的机制]
Farmakol Toksikol. 1986 Sep-Oct;49(5):90-2.
2
[Mechanisms of the anti-anginal effect of korinfar].[科林法尔抗心绞痛作用的机制]
Farmakol Toksikol. 1988 Sep-Oct;51(5):38-41.
3
[A comparative evaluation of the antianginal efficacy of aldizem and korinfar in patients with stable stenocardia].[阿地洛尔与可立夫在稳定型心绞痛患者中抗心绞痛疗效的比较评估]
Ter Arkh. 1991;63(8):50-2.
4
[The clinical pharmacology and efficacy of the new Soviet calcium antagonist foridon].[苏联新型钙拮抗剂福立顿的临床药理学与疗效]
Ter Arkh. 1990;62(10):138-42.
5
[Comparative pharmacodynamics study of korinfar and isoptin in ischemic heart disease].[科力法与异搏定在缺血性心脏病中的比较药效学研究]
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR. 1981;4(1):64-70.
6
[Calcium metabolism and the diastolic rigidity status of the myocardium in patients with ischemic heart disease under the influence of calcium antagonist treatment].[钙拮抗剂治疗对缺血性心脏病患者钙代谢及心肌舒张僵硬状态的影响]
Fiziol Zh (1978). 1992 Jan-Feb;38(1):22-6.
7
[The use of the delayed-action form of korinfar in arterial hypertension, stenocardia and hypertrophic cardiomyopathy].[korinfar延迟作用剂型在动脉高血压、心绞痛和肥厚型心肌病中的应用]
Ter Arkh. 1996;68(1):39-42.
8
[Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].[评估氨氯地平和硝苯地平缓释片对稳定型劳力性心绞痛合并高血压患者疗效及不良反应的对比研究]
Przegl Lek. 1997;54(5):324-8.
9
Clinical efficacy of niludipine in the treatment of angina pectoris.尼鲁地平治疗心绞痛的临床疗效。
Arzneimittelforschung. 1984;34(5):614-9.
10
[The comparative efficacy of nicardipine and nifedipine in stenocardia patients].[尼卡地平与硝苯地平对心绞痛患者的疗效比较]
Ter Arkh. 1990;62(10):142-5.